西红花酸对糖尿病大鼠体内晚期糖基化终产物的形成及其受体表达的影响

摘要/Abstract

摘要： 目的:观察西红花酸对糖尿病(diabetic mellitus, DM)大鼠晚期糖基化终产物(AGEs)的形成和受体(RAGE)蛋白表达的影响。方法:以链脲佐菌素诱导DM 大鼠模型, 并将DM 大鼠随机分为DM 模型组和西红花酸治疗组(50 mg·kg^-1 ·d^-1), 另设正常组,给药21 d 后, 血糖仪测定大鼠空腹血糖;试剂盒分别测定AGEs 中间产物即血清果糖胺(FMN)和糖化血红蛋白(GHb)的含量;荧光分光光度法测定主动脉及肠系膜血管床AGEs 的水平;病理切片观察肠系膜动脉的变化;免疫组化法检测RAGE 蛋白在肠系膜动脉中的表达。结果:西红花酸治疗后, 对DM大鼠血糖值无明显影响;但FMN 和GHb 水平与模型组比明显下降;AGEs 在主动脉和肠系膜血管床中沉积减少;肠系膜动脉血管损伤减轻;RAGE 蛋白表达显著下降。结论:西红花酸可抑制蛋白质非酶糖化反应, 减少AGEs 及其中间产物的形成, 下调RAGE 蛋白表达, 保护DM 大鼠血管。

关键词: 西红花酸, 晚期糖基化终产物, 晚期糖基化终产物受体, 糖尿病, 糖尿病血管病变

Abstract: AIM: To study the effect of crocetin on the formation of advanced glycation end products (AGEs) and receptor forAGEs (RAGE)protein expression in diabetic rats induced by streptozotocin (STZ).METHODS: Rats were injected STZ in tail vessel with a dose of 45 mg·kg ^-1.3 d later, the rats whose blood glucose were over 11.1 mmol·L ^-1 were regarded as diabetic rats, and were divided randomly into two groups:diabetic mellitus (DM)group, crocetin (50 mg·kg ^-1, po)group.At the same time, 8 normal rats were regarded as control group. After 21 d treatment, The levels of fasting blood glucose (FBG), serum fructosamine (FMN)and glycosylated hemoglobin (GHb)were measured.The contents of AGEs in aorta and mesenteric vessel were detected by fluorospectrophotometry.HE staining for mesenteric aorta was performed, and RAGE protein expression was studies with immunohistochemical method.RESULTS: Compared with DM group, crocetin did not decrease the level of FBG.However, it could decrease the levels of FMN and GHb in blood and AGEs in aorta and mesenteric vessel (P <0.01 or 0.05).HE staining demonstrated injure of mesenteric aorta attenuated and RAGE protein expression decreased after crocetin treatment.CONCLUSION: These results suggest that crocetin not only inhibit nonenzymatic glycation reaction but also reduce RAGE protein expression in diabetic rats, which may contribute to attenuate diabetic vascular complications.

Key words: crocetin, advanced glycation endoproducts, receptor for advanced glycation endoproducts, diabetic mellitus, diabetic vascular complication

中图分类号:

R965.1

向敏, 钱之玉, 周成华. 西红花酸对糖尿病大鼠体内晚期糖基化终产物的形成及其受体表达的影响[J]. 中国临床药理学与治疗学, 2006, 11(4): 448-452.

XIANG Min, QIAN Zhi-yu, ZHOU Cheng-hua. Effects of crocetin on formation of advanced glycation end products and expression of releptor for advanced glycation and prodmts protein in diabetic rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 448-452.

参考文献

1 Zimmet P, Albeti KG, Shaw J.Global and societal implications of the diabetes epidemic[J].Nature, 2001;414:782-7
2 Rojas A, Morales MA.Advanced glycation and endothelial functions:A link towards vascular complications in diabetes[J]. Life Sciences, 2004;76:715-30
3 Ahmed N.Advanced gly cation endproducts-role in pathology of diabetic complications[J].Diabetes Res Clin Pract, 2005;67:3-21
4 Yan SF, Ramasamy R, Naka Y, Schmidt AM.Glycation, inflammation, and RAGE:a scaffold for the macrovascular complications of diabetes and beyond[J].Circ Res, 2003;93:1159-69
5 李文娜, 钱之玉.西红花酸对阿霉素所致大鼠心肌线粒体损伤的影响[J].中国临床药理学与治疗学, 2005;10:764-8
6 Xi L, Qian ZY, Shen XC, Wen N, Zhang YB.Crocetin prevents dexamethasone-induced insulin resistance in rats [J]. Planta Med, 2005;71:917-22
7 王雅娟, 钱之玉, 沈祥春.西红花酸对体外蛋白质非酶糖基化的抑制作用[J].中草药, 2005;36:1202-5
8 Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, et al.Vascular hypertrophy in experimental diabetes.Role of advanced glycation end products[J].J Clin Invest, 1997;99: 1016-27
9 Makita M, Vlassara H, Cerami A, Bucala R.Immunochemical detection of advanced glycosy lation end products in vivo[J].J Biol Chem, 1992;267:5133-8
10 Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al.Endothelial cells in physiology and in the pathophysiology of vascular disorders[J].Blood, 1998;91: 3527-60
11 Ledingham JM, Laverty R.Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model[J].Clin Exp Pharmacol Physiol, 2005;32:76-85
12 Simonsen U, Ehrnrooth E, Gerdes LU, Faergemann O, Buch J, Andreasen F, et al.Functional properties in vitro of systematicsmall arteries from rabbits fed a cholesterol-rich diet for 12 weeks[J].Clin Sci(Lond), 1991;80:119-29
13 Gilbert RE, Rumble JR, Cao Z, Cox AJ, Eeden PV, Allen TJ, et al.Endothelin receptor antagonism ameliorated mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes[J].Circ Res, 2000;86: 158-65
14 Wautier MP, Massin P, Guillausseau PJ, Huijbert M, Levy B, Boulanger E, et al.N-(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients[J]. DiabetesMetab, 2003;29:44-52
15 Ido Y, Chang KC, Lejeune WS, Bjercke RJ, Reiser KM, Williamson JR, et al.Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C[J].Microcirculation, 2001;8:251-63
16 Moore TCB, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, et al.The role of advanced glycation end products in retinal microvascular leukostasis[J].Invest Ophthalmol Vis Sci, 2003;44:4457-64
17 Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al.Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins[J].J Biol Chem, 1992;267:14898-5004
18 Wang R, Kudo M, Yokoyama M, Asano G.Roles of advanced glycation end products (AGE)and receptor for AGE on vascular smooth muscle cell growth[J].J Nippon Med Sch, 2001;68: 472-81
19 Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, et al.Two novel rat liver membrane proteins that Bind Advanced Gly cosylation Endproducts:Relationship to Macrophage Receptor for Glucose-modified Proteins[J].J Exp Med, 1991; 174:515-24
20 Miura J, Uchigata Y, Yamamoto Y, Takeuchi M, Sakurai S, Watanabe T, et al.AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes[J].J Diabetes Complications, 2004;18:53-9
21 Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, et al.Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice[J].Arterioscler Thromb Vasc Biol, 2001;21:905-10
22 Ritthaler U, Roth H, Bierhaus A, Ziegler R, Schmidt AM, Waldherr R, et al.Expression of RAGE in peripheral occlusive vascular disease[J].Am J Pathol, 1995;146:688-94
23 Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, et al.RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice[J].Circulation, 2002;106: 2827-35

[1]	马言, 田高鹏, 石兴文, 孙婷, 谢晶晶, 甄东户. 探讨T2DM人群中25（OH）D与代谢相关性脂肪肝的相关性[J]. 中国临床药理学与治疗学, 2023, 28(9): 1018-1026.
[2]	许宜琪, 吴茜, 刘书, 刘帆, 邢春燕, 李勤, 何俊俊, 何春玲, 赵咏莉, 高家林. 雷公藤多苷治疗糖尿病肾脏病的临床疗效及抗炎抗纤维化分析[J]. 中国临床药理学与治疗学, 2023, 28(9): 1034-1042.
[3]	马仙康, 杨丽霞, 崔阳阳, 米登海. 当归多糖通过抑制GRP78、p-PERK、p-Eif2α表达改善糖尿病KK-Ay小鼠肝内质网应激[J]. 中国临床药理学与治疗学, 2023, 28(8): 926-936.
[4]	李坤, 李璐璐, 李楠楠, 胡卫红, 周建超. 成人肾移植术后血糖控制和CYP3A5基因多态性对他克莫司谷浓度的影响[J]. 中国临床药理学与治疗学, 2023, 28(7): 767-774.
[5]	侯瑞英, 郭莉阁, 焦伟杰, 杜蕾, 吴桂月, 赵旭. 消渴舒方对2型糖尿病模型大鼠血清炎症因子的影响及其机制研究[J]. 中国临床药理学与治疗学, 2023, 28(4): 377-382.
[6]	张雪娇, 刘洁婷, 李鲁新, 陈培剑, 丁明璐, 孙梦伟, 初彦辉, 张珍. 达格列净对1型糖尿病小鼠心肌损伤的影响及机制研究[J]. 中国临床药理学与治疗学, 2023, 28(3): 257-265.
[7]	白佳, 杨虹, 李玲玲, 张洋洋, 杨莹, 吕海宏. 维生素D通过线粒体/自噬途径影响糖尿病神经病变机制的研究[J]. 中国临床药理学与治疗学, 2023, 28(2): 214-219.
[8]	赵世峰, 宋向明, 姚建平. 新型胰高血糖素样肽-1受体/葡萄糖依赖性促胰岛素多肽受体双重激动剂——Tirzepatide[J]. 中国临床药理学与治疗学, 2023, 28(2): 220-227.
[9]	杜小雨, 李宇蒙, 吴惠珍, 邱博. 多格列艾汀治疗2型糖尿病的药理作用和临床评价[J]. 中国临床药理学与治疗学, 2023, 28(10): 1177-1183.
[10]	蔡静, 潘斌晶, 刘靖芳. 降糖药物与肌肉减少症关系的研究进展[J]. 中国临床药理学与治疗学, 2023, 28(1): 101-108.
[11]	杨丽, 柏虎虎, 贺沙沙, 金月, 刘成松. TRPM3的酪氨酸磷酸化参与糖尿病诱发的热痛觉过敏[J]. 中国临床药理学与治疗学, 2022, 27(9): 971-976.
[12]	翟葳葳, 余巧玲, 刘平, 邱博, 吴惠珍. 非奈利酮在2型糖尿病合并慢性肾病治疗中的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(9): 1067-1074.
[13]	卢森林, 刘欣元, 王吉莉, 黄晓飞. 病毒载体介导的基因治疗在2型糖尿病中的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(7): 800-807.
[14]	金依依, 周科挺, 杨成成, 徐萍, 朱素燕. 蛇床子素抑制NF-κB和p38/MAPK改善糖尿病诱导的肾脏损伤[J]. 中国临床药理学与治疗学, 2022, 27(6): 622-631.
[15]	王珍, 全海燕, 洪陈亮, 袁李佳龙, 秦旭平. 游泳运动通过促进自噬改善糖尿病小鼠肾功能的研究[J]. 中国临床药理学与治疗学, 2022, 27(6): 632-638.